...
首页> 外文期刊>Bone marrow transplantation >Application of the CIBMTR One Year Survival Outcomes Calculator as a tool for retrospective analysis
【24h】

Application of the CIBMTR One Year Survival Outcomes Calculator as a tool for retrospective analysis

机译:CIBMTR 一年生存结果计算器作为回顾性分析工具的应用

获取原文
获取原文并翻译 | 示例

摘要

Abstract The Web-based One Year Survival Outcomes Calculator developed by the Center for International Blood and Marrow Transplant Research (CIBMTR) applies large-scale registry data to generate individualized estimates of overall survival (OS) probability 1 year after first allogeneic hematopoietic cell transplant (HCT) and can therefore provide a data-driven foundation for personalized patient counseling. We assessed the calibration of the CIBMTR One Year Survival Outcomes Calculator when applied to retrospective data among adult recipients of first allogeneic HCT for acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), or myelodysplastic syndrome (MDS) with peripheral blood stem cell transplant (PBSCT) from a 7/8- or 8/8-matched donor from 2000 through 2015 at a single center. Predicted 1 year OS was estimated for each patient using the CIBMTR Calculator. Corresponding observed 1 year OS was estimated for each group by the Kaplan-Meier method. A weighted Kaplan-Meier estimator was used to visually display the average of observed 1 year survival estimates over the continuous range of predicted OS. In the first analysis of its kind, we demonstrated that the CIBMTR One Year Survival Outcomes Calculator could be applied to larger patient cohorts and predicted 1 year prognosis with general agreement between predicted and observed survival.
机译:摘要 国际血液和骨髓移植研究中心(CIBMTR)开发的基于网络的一年生存结果计算器应用大规模注册数据对首次同种异体造血细胞移植(HCT)后1年的总生存率(OS)概率进行个体化估计,因此可以为个性化患者咨询提供数据驱动的基础。我们评估了 CIBMTR 一年生存结果计算器在应用于 2000 年至 2015 年来自单个中心的 7/8 或 8/8 匹配供体的首次同种异体 HCT 的急性髓系白血病 (AML)、急性淋巴细胞白血病 (ALL) 或骨髓增生异常综合征 (MDS) 的成年接受者的回顾性数据时的校准。使用 CIBMTR 计算器估计每位患者的预测 1 年 OS。通过Kaplan-Meier方法估计每组的相应观察1年OS。使用加权 Kaplan-Meier 估计器直观地显示观察到的 1 年生存估计值在预测 OS 的连续范围内的平均值。在同类分析中,我们证明了 CIBMTR 一年生存结果计算器可以应用于更大的患者队列并预测 1 年预后,预测生存率和观察到的生存率之间基本一致。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号